Indie Bio

What is Indie Bio?

IndieBio is recognized as the world's first accelerator specifically dedicated to startups that leverage biology to address major global issues. As an initiative under the aegis of SOSV—a globally situated venture capital firm that provides multi-stage investment—IndieBio's mandate is to back bold ideas capable of engendering profound change.

They invest in early-stage biotech companies and nurture them through a combination of capital, mentorship, and access to a network to help them scale rapidly and realize their visions. IndieBio offers substantial initial investment and has a broad portfolio encompassing various sectors such as climate, food, therapeutics, and materials where biological innovation holds transformative potential.

They highlight their commitment to diversity with a staggering 42% of the female founders among their funded companies. With over 270 companies supported and over $12 billion in value created, they demonstrate their influence across 40 countries. IndieBio presents a cooperative approach, seeking long-term partnerships with its startups and positioning itself as part of founders' long-term growth trajectories.

The program asserts its originality and leadership in early-stage deep tech and biotech, consistently improving to offer personal attention and bespoke support through their teams in San Francisco and New York. Companies currently within their investment purview are profiled for potential investors, emphasizing ongoing opportunities in groundbreaking technology development.

IndieBio continues to engage with the broader biotech community through diverse avenues including job opportunities within its extensive network, events and thought leadership platforms, and corporate partnerships. Their comprehensive online presence reiterates their intention to fortify and expand the impact of biotech startups, underscoring significant milestones and breakthroughs in human and planetary health.